| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 63 | 2022 | 731 | 10.240 |
Why?
|
| Heart Failure | 51 | 2022 | 1203 | 6.860 |
Why?
|
| Heart Transplantation | 10 | 2023 | 705 | 3.570 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2021 | 462 | 2.880 |
Why?
|
| Heart Valve Prosthesis Implantation | 10 | 2023 | 166 | 2.570 |
Why?
|
| Ventricular Function, Left | 21 | 2021 | 592 | 2.430 |
Why?
|
| Diverticulum | 4 | 2021 | 44 | 2.260 |
Why?
|
| Hemodynamics | 17 | 2020 | 710 | 2.180 |
Why?
|
| Tissue Engineering | 7 | 2016 | 181 | 2.090 |
Why?
|
| Aorta, Thoracic | 8 | 2022 | 165 | 1.990 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2021 | 130 | 1.860 |
Why?
|
| Prosthesis Implantation | 9 | 2020 | 125 | 1.770 |
Why?
|
| Retrospective Studies | 48 | 2023 | 8475 | 1.710 |
Why?
|
| Heart Ventricles | 16 | 2020 | 760 | 1.680 |
Why?
|
| Subclavian Artery | 4 | 2021 | 44 | 1.630 |
Why?
|
| Tricuspid Valve Insufficiency | 5 | 2023 | 111 | 1.470 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2021 | 87 | 1.430 |
Why?
|
| Cannula | 7 | 2020 | 47 | 1.340 |
Why?
|
| Heart Valve Diseases | 4 | 2018 | 109 | 1.330 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 232 | 1.330 |
Why?
|
| Aortic Valve | 12 | 2021 | 222 | 1.330 |
Why?
|
| Coronary Sinus | 2 | 2020 | 7 | 1.320 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 17 | 1.310 |
Why?
|
| Middle Aged | 80 | 2022 | 25017 | 1.310 |
Why?
|
| Pericardium | 7 | 2018 | 65 | 1.310 |
Why?
|
| Intra-Aortic Balloon Pumping | 6 | 2022 | 78 | 1.280 |
Why?
|
| Humans | 116 | 2023 | 86601 | 1.210 |
Why?
|
| Myocardium | 5 | 2021 | 529 | 1.210 |
Why?
|
| Treatment Outcome | 38 | 2023 | 7988 | 1.180 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 139 | 1.170 |
Why?
|
| Hospital Mortality | 6 | 2022 | 348 | 1.140 |
Why?
|
| Postoperative Complications | 15 | 2022 | 2207 | 1.130 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 115 | 1.120 |
Why?
|
| Sternotomy | 3 | 2022 | 20 | 1.110 |
Why?
|
| Mitral Valve | 7 | 2021 | 248 | 1.110 |
Why?
|
| Heart Atria | 5 | 2020 | 250 | 1.080 |
Why?
|
| Device Removal | 4 | 2020 | 161 | 1.040 |
Why?
|
| Male | 81 | 2022 | 40956 | 1.040 |
Why?
|
| Aged | 54 | 2022 | 18402 | 1.020 |
Why?
|
| Female | 82 | 2022 | 44507 | 1.020 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2020 | 229 | 0.990 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 13 | 0.950 |
Why?
|
| Ventricular Function, Right | 5 | 2020 | 142 | 0.940 |
Why?
|
| Aortic Rupture | 2 | 2022 | 55 | 0.930 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 23 | 0.930 |
Why?
|
| Catheter Ablation | 5 | 2008 | 233 | 0.930 |
Why?
|
| Regeneration | 3 | 2016 | 143 | 0.900 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2021 | 208 | 0.900 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2020 | 134 | 0.880 |
Why?
|
| Robotics | 4 | 2011 | 267 | 0.860 |
Why?
|
| Recovery of Function | 5 | 2021 | 272 | 0.830 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2016 | 187 | 0.800 |
Why?
|
| Ventricular Remodeling | 2 | 2015 | 96 | 0.790 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 93 | 0.780 |
Why?
|
| Swine | 12 | 2017 | 555 | 0.780 |
Why?
|
| Thrombosis | 5 | 2020 | 296 | 0.780 |
Why?
|
| Tricuspid Valve | 5 | 2023 | 96 | 0.760 |
Why?
|
| Echocardiography, Doppler | 8 | 2020 | 187 | 0.730 |
Why?
|
| Heart Arrest, Induced | 2 | 2020 | 31 | 0.730 |
Why?
|
| Pulmonary Wedge Pressure | 6 | 2020 | 108 | 0.720 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 74 | 0.720 |
Why?
|
| Heart Rate | 2 | 2022 | 492 | 0.710 |
Why?
|
| Heart | 5 | 2019 | 539 | 0.710 |
Why?
|
| Vena Cava, Superior | 2 | 2020 | 59 | 0.710 |
Why?
|
| Endocarditis, Bacterial | 2 | 2011 | 33 | 0.690 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 267 | 0.690 |
Why?
|
| Defibrillators, Implantable | 3 | 2021 | 129 | 0.670 |
Why?
|
| Pacemaker, Artificial | 3 | 2020 | 87 | 0.650 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 188 | 0.650 |
Why?
|
| Cardiac Catheterization | 6 | 2020 | 291 | 0.650 |
Why?
|
| Time Factors | 17 | 2020 | 5209 | 0.640 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 237 | 0.640 |
Why?
|
| Thromboembolism | 4 | 2019 | 119 | 0.630 |
Why?
|
| Coronary Artery Bypass | 3 | 2020 | 228 | 0.590 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2018 | 516 | 0.590 |
Why?
|
| Survival Rate | 8 | 2022 | 1860 | 0.590 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2008 | 84 | 0.590 |
Why?
|
| Follow-Up Studies | 17 | 2020 | 3636 | 0.580 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2015 | 318 | 0.550 |
Why?
|
| Cohort Studies | 9 | 2022 | 2767 | 0.540 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 57 | 0.530 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2015 | 7 | 0.530 |
Why?
|
| Prosthesis Design | 11 | 2020 | 278 | 0.520 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.510 |
Why?
|
| Drug Carriers | 1 | 2015 | 81 | 0.510 |
Why?
|
| Counterpulsation | 3 | 2020 | 21 | 0.510 |
Why?
|
| Adult | 29 | 2022 | 25640 | 0.510 |
Why?
|
| Aneurysm | 1 | 2015 | 58 | 0.500 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2017 | 663 | 0.500 |
Why?
|
| Electrocardiography | 6 | 2021 | 478 | 0.490 |
Why?
|
| Cysts | 1 | 2015 | 104 | 0.480 |
Why?
|
| Shock, Cardiogenic | 4 | 2017 | 94 | 0.480 |
Why?
|
| Echocardiography | 12 | 2020 | 911 | 0.470 |
Why?
|
| Endoscopy | 3 | 2020 | 332 | 0.460 |
Why?
|
| Intestine, Small | 1 | 2015 | 303 | 0.460 |
Why?
|
| Atrial Fibrillation | 4 | 2018 | 288 | 0.460 |
Why?
|
| Risk Assessment | 9 | 2021 | 2261 | 0.460 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2013 | 44 | 0.450 |
Why?
|
| Stroke Volume | 5 | 2022 | 456 | 0.440 |
Why?
|
| Prospective Studies | 20 | 2020 | 4210 | 0.440 |
Why?
|
| Cardiac Output | 5 | 2020 | 156 | 0.440 |
Why?
|
| Reoperation | 7 | 2020 | 597 | 0.430 |
Why?
|
| Heart Injuries | 1 | 2011 | 16 | 0.410 |
Why?
|
| Chordae Tendineae | 3 | 2015 | 23 | 0.400 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2011 | 92 | 0.390 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 94 | 0.380 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 857 | 0.360 |
Why?
|
| Mathematical Concepts | 2 | 2020 | 18 | 0.360 |
Why?
|
| Risk Factors | 15 | 2022 | 5416 | 0.360 |
Why?
|
| Thoracotomy | 3 | 2021 | 58 | 0.360 |
Why?
|
| Bioprosthesis | 3 | 2017 | 36 | 0.360 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 46 | 0.350 |
Why?
|
| Anticoagulants | 5 | 2019 | 408 | 0.350 |
Why?
|
| Hematoma | 1 | 2010 | 104 | 0.340 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 51 | 0.340 |
Why?
|
| Aorta | 5 | 2022 | 280 | 0.330 |
Why?
|
| Injections | 1 | 2008 | 109 | 0.330 |
Why?
|
| Incidence | 7 | 2021 | 1576 | 0.330 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 10 | 0.320 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 2705 | 0.320 |
Why?
|
| Body Surface Potential Mapping | 1 | 2007 | 22 | 0.310 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2014 | 148 | 0.310 |
Why?
|
| Equipment Design | 5 | 2016 | 406 | 0.310 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 159 | 0.300 |
Why?
|
| Atrial Function, Left | 1 | 2007 | 46 | 0.300 |
Why?
|
| Guanidines | 1 | 2007 | 31 | 0.300 |
Why?
|
| Gamma Rays | 1 | 2007 | 72 | 0.300 |
Why?
|
| Heart Valve Prosthesis | 3 | 2021 | 93 | 0.300 |
Why?
|
| Assisted Circulation | 2 | 2018 | 15 | 0.300 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 72 | 0.290 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 115 | 0.290 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 99 | 0.290 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2015 | 344 | 0.290 |
Why?
|
| Recurrence | 5 | 2018 | 1139 | 0.290 |
Why?
|
| Hemorrhage | 2 | 2018 | 268 | 0.280 |
Why?
|
| Animals | 17 | 2017 | 26581 | 0.280 |
Why?
|
| Intracranial Hemorrhages | 1 | 2007 | 120 | 0.270 |
Why?
|
| Network Meta-Analysis | 2 | 2022 | 7 | 0.270 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2020 | 35 | 0.260 |
Why?
|
| Registries | 4 | 2022 | 702 | 0.260 |
Why?
|
| Fibronectins | 1 | 2005 | 93 | 0.260 |
Why?
|
| Xiphoid Bone | 3 | 2009 | 3 | 0.260 |
Why?
|
| Models, Animal | 2 | 2016 | 263 | 0.250 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 363 | 0.250 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1267 | 0.250 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 351 | 0.250 |
Why?
|
| Stroke | 4 | 2022 | 965 | 0.250 |
Why?
|
| Atrial Appendage | 2 | 2018 | 26 | 0.250 |
Why?
|
| Chicago | 2 | 2019 | 1379 | 0.240 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 305 | 0.240 |
Why?
|
| Sensitivity and Specificity | 7 | 2017 | 1990 | 0.230 |
Why?
|
| Endocarditis | 2 | 2021 | 18 | 0.230 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 435 | 0.230 |
Why?
|
| Central Venous Pressure | 2 | 2020 | 26 | 0.230 |
Why?
|
| Hypothermia | 1 | 2022 | 26 | 0.220 |
Why?
|
| Equipment Failure | 4 | 2018 | 119 | 0.220 |
Why?
|
| Arterial Pressure | 2 | 2020 | 38 | 0.220 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 244 | 0.220 |
Why?
|
| Exercise Tolerance | 2 | 2020 | 48 | 0.220 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 579 | 0.220 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 121 | 0.220 |
Why?
|
| Perfusion | 2 | 2022 | 203 | 0.220 |
Why?
|
| Hypothermia, Induced | 1 | 2022 | 74 | 0.210 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2015 | 39 | 0.210 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 38 | 0.210 |
Why?
|
| Propensity Score | 1 | 2022 | 136 | 0.210 |
Why?
|
| Feasibility Studies | 6 | 2020 | 751 | 0.210 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 197 | 0.200 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 218 | 0.200 |
Why?
|
| Patient Readmission | 3 | 2020 | 329 | 0.200 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 212 | 0.200 |
Why?
|
| Aortic Valve Stenosis | 2 | 2017 | 131 | 0.200 |
Why?
|
| Aortic Diseases | 1 | 2022 | 100 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2020 | 350 | 0.200 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 181 | 0.200 |
Why?
|
| Dogs | 5 | 2010 | 685 | 0.190 |
Why?
|
| Axillary Artery | 1 | 2020 | 10 | 0.190 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 29 | 0.190 |
Why?
|
| Image Enhancement | 4 | 2017 | 563 | 0.190 |
Why?
|
| Tissue Donors | 1 | 2023 | 463 | 0.190 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 1801 | 0.190 |
Why?
|
| Ambulatory Care | 2 | 2018 | 181 | 0.190 |
Why?
|
| Cause of Death | 2 | 2018 | 277 | 0.180 |
Why?
|
| Hemoglobins | 2 | 2018 | 179 | 0.180 |
Why?
|
| Foreign Bodies | 1 | 2020 | 63 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3352 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 80 | 0.180 |
Why?
|
| Breath Holding | 2 | 2017 | 22 | 0.180 |
Why?
|
| Drainage | 1 | 2020 | 157 | 0.180 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 71 | 0.180 |
Why?
|
| Postoperative Period | 1 | 2020 | 303 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2020 | 104 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 152 | 0.170 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 143 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 860 | 0.170 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 364 | 0.170 |
Why?
|
| Heparin | 1 | 2019 | 175 | 0.170 |
Why?
|
| Delayed-Action Preparations | 2 | 2018 | 116 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 231 | 0.170 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 19 | 0.170 |
Why?
|
| Heart Function Tests | 1 | 2018 | 30 | 0.170 |
Why?
|
| Electromagnetic Phenomena | 2 | 2008 | 18 | 0.170 |
Why?
|
| Donor Selection | 1 | 2019 | 67 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 295 | 0.170 |
Why?
|
| Operative Time | 1 | 2019 | 127 | 0.170 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 26 | 0.170 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1673 | 0.170 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 29 | 0.170 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 379 | 0.160 |
Why?
|
| Cicatrix | 1 | 2018 | 63 | 0.160 |
Why?
|
| Enoxaparin | 1 | 2018 | 23 | 0.160 |
Why?
|
| Intraoperative Care | 1 | 2018 | 82 | 0.160 |
Why?
|
| Octreotide | 1 | 2018 | 16 | 0.160 |
Why?
|
| Prosthesis Failure | 3 | 2016 | 111 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 187 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 162 | 0.150 |
Why?
|
| Algorithms | 5 | 2017 | 1830 | 0.150 |
Why?
|
| Prognosis | 5 | 2018 | 3674 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 47 | 0.140 |
Why?
|
| Patient Selection | 1 | 2020 | 685 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2232 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 80 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 345 | 0.140 |
Why?
|
| Hospitalization | 1 | 2022 | 848 | 0.140 |
Why?
|
| Subtraction Technique | 1 | 2016 | 133 | 0.140 |
Why?
|
| Action Potentials | 2 | 2018 | 573 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 31 | 0.130 |
Why?
|
| Sus scrofa | 1 | 2015 | 45 | 0.130 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2016 | 58 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1019 | 0.130 |
Why?
|
| Jehovah's Witnesses | 1 | 2015 | 18 | 0.130 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 311 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2600 | 0.130 |
Why?
|
| Ultrasonography | 2 | 2015 | 695 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 999 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 375 | 0.130 |
Why?
|
| Coronary Vessels | 1 | 2016 | 177 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 148 | 0.120 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 267 | 0.120 |
Why?
|
| Heart Septum | 1 | 2014 | 45 | 0.120 |
Why?
|
| Hemolysis | 1 | 2013 | 61 | 0.120 |
Why?
|
| Illinois | 3 | 2019 | 462 | 0.110 |
Why?
|
| Ribs | 1 | 2012 | 45 | 0.110 |
Why?
|
| Software | 1 | 2017 | 654 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 228 | 0.110 |
Why?
|
| Acute Disease | 3 | 2021 | 826 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2018 | 1538 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 261 | 0.110 |
Why?
|
| Quality of Life | 1 | 2020 | 1583 | 0.100 |
Why?
|
| Therapeutics | 1 | 2011 | 12 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1718 | 0.100 |
Why?
|
| United States | 6 | 2020 | 6665 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 143 | 0.100 |
Why?
|
| Confidence Intervals | 1 | 2011 | 229 | 0.100 |
Why?
|
| Saphenous Vein | 1 | 2010 | 61 | 0.100 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.100 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 78 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 87 | 0.090 |
Why?
|
| Absorbable Implants | 1 | 2009 | 34 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2011 | 678 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2010 | 912 | 0.090 |
Why?
|
| Vacuum | 1 | 2008 | 10 | 0.080 |
Why?
|
| Polyethylene Terephthalates | 1 | 2008 | 17 | 0.080 |
Why?
|
| Mitral Valve Prolapse | 1 | 2008 | 22 | 0.080 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2008 | 16 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2008 | 64 | 0.080 |
Why?
|
| Heart Septal Defects | 1 | 2008 | 31 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 231 | 0.080 |
Why?
|
| Capillaries | 1 | 2008 | 91 | 0.080 |
Why?
|
| Pressure | 1 | 2008 | 165 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 827 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 90 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 6501 | 0.080 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1753 | 0.080 |
Why?
|
| Benzamidines | 1 | 2007 | 2 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 134 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 269 | 0.070 |
Why?
|
| Exercise Test | 2 | 2019 | 164 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1920 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 1054 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 557 | 0.070 |
Why?
|
| User-Computer Interface | 1 | 2008 | 185 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2008 | 246 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 879 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 989 | 0.070 |
Why?
|
| Reference Values | 2 | 2018 | 674 | 0.070 |
Why?
|
| Age Factors | 2 | 2022 | 1849 | 0.070 |
Why?
|
| Actins | 1 | 2008 | 451 | 0.070 |
Why?
|
| Disease Progression | 2 | 2020 | 1531 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 927 | 0.060 |
Why?
|
| Observer Variation | 2 | 2016 | 602 | 0.060 |
Why?
|
| Child | 1 | 2015 | 6926 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 758 | 0.060 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 5 | 0.060 |
Why?
|
| Respiration | 2 | 2017 | 262 | 0.060 |
Why?
|
| Coronary Angiography | 2 | 2016 | 232 | 0.050 |
Why?
|
| Temperature | 1 | 2022 | 396 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2021 | 173 | 0.050 |
Why?
|
| Abscess | 1 | 2021 | 91 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 41 | 0.050 |
Why?
|
| Rats | 1 | 2007 | 3990 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 106 | 0.050 |
Why?
|
| Hemodynamic Monitoring | 1 | 2019 | 8 | 0.050 |
Why?
|
| Global Health | 1 | 2021 | 193 | 0.040 |
Why?
|
| Mammary Arteries | 1 | 2020 | 31 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 91 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 377 | 0.040 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.040 |
Why?
|
| Epicardial Mapping | 1 | 2018 | 10 | 0.040 |
Why?
|
| Succinylcholine | 1 | 2018 | 14 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 129 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 364 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 62 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 38 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 283 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
| Pneumonia | 1 | 2018 | 179 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 8979 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 5974 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 134 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 96 | 0.040 |
Why?
|
| Gadolinium | 1 | 2017 | 103 | 0.040 |
Why?
|
| Equipment Safety | 1 | 2016 | 31 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 161 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 700 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 293 | 0.030 |
Why?
|
| Artifacts | 1 | 2017 | 244 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 87 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 156 | 0.030 |
Why?
|
| New York | 1 | 2014 | 69 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 108 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 429 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1961 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3611 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2015 | 394 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 71 | 0.030 |
Why?
|
| Basilar Artery | 1 | 2011 | 41 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 2011 | 23 | 0.030 |
Why?
|
| Acceleration | 1 | 2011 | 20 | 0.030 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 27 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 1077 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2011 | 201 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2010 | 126 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 153 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 131 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 99 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 135 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 79 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 238 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 75 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1239 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 376 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1185 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1685 | 0.020 |
Why?
|